| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edwards Lifesciences Corporation (EW) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. EW is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 215.9K | $19.59M | - | |
| VP | 98.6K | $8.95M | - | |
| CFO | 46.7K | $4.24M | - | |
| VP | 44.3K | $4.02M | - | |
| VP | 40.4K | $3.67M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2019 | Szyman Catherine M.67 | Cvp, Critical Care | Sale+OE | 2,500 | $234.27 | $585,686.50 | -12.8% | |
| Dec 12, 2019 | Mussallem Michael A65 | Chairman &CEO | Sale+OE | 22,850 | $229.60 | $5,246,390.36 | -8.8% | |
| Dec 11, 2019 | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sale+OE | 5,369 | $229.26 | $1,230,896.94 | -20.6% | |
| Dec 10, 2019 | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sale+OE | 7,500 | $233.88 | $1,754,100.00 | -43.0% | |
| Dec 9, 2019 | Wang Huimin68 | Cvp, Japan &Intercontinental | Sale+OE | 4,650 | $238.56 | $1,109,304.00 | -12.6% | |
| Dec 9, 2019 | Wood Larry L67 | Cvp, Tavr | Sale+OE | 6,724 | $238.56 | $1,604,077.44 | -5.4% | |
| Nov 15, 2019 | Mussallem Michael A65 | Chairman &CEO | Sale+OE | 22,850 | $244.56 | $5,588,142.53 | -6.2% | |
| Nov 15, 2019 | Szyman Catherine M.67 | Cvp, Critical Care | Sale+OE | 2,500 | $242.14 | $605,350.00 | -12.8% | |
| Nov 12, 2019 | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sale+OE | 7,500 | $234.28 | $1,757,100.00 | -43.0% | |
| Nov 8, 2019 | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sale+OE | 5,369 | $234.37 | $1,258,332.53 | -20.6% |